ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,400Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 890

$930K Total Retail Price of All Prescriptions

Rank: 59 out of 890

502 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

12% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 15,612 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 781 602 1 5
AMLODIPINE BESYLATE 713 584 2 1
WARFARIN SODIUM 655 587 3 24
LEVOTHYROXINE SODIUM 582 473 4 2
GLIMEPIRIDE 420 330 5 27
OMEPRAZOLE 419 329 6 8
FUROSEMIDE 401 347 7 7
TRAMADOL HCL 374 290 8 16
METFORMIN HCL 355 301 9 6
LISINOPRIL 344 228 10 4
PRAVASTATIN SODIUM 342 301 11 10
ATENOLOL 326 269 12 23
MELOXICAM 273 239 13 18
LACTULOSE 269 241 14 112
POTASSIUM CHLORIDE 264 227 15 11
ATORVASTATIN CALCIUM 254 192 16 13
HYDROCODONE-ACETAMINOPHEN 247 130 S3 17 3
METOPROLOL SUCCINATE 244 210 18 17
CITALOPRAM HBR 228 199 19 20
JANUVIA 210 173 20 59
CLONIDINE HCL 188 149 21 35
NEXIUM 186 144 22 14
DONEPEZIL HCL 186 170 22 30
SERTRALINE HCL 179 126 24 26
NAMENDA 177 149 25 36
RANITIDINE HCL 168 129 26 49
METOPROLOL TARTRATE 163 124 27 15
ALLOPURINOL 163 123 27 31
BENAZEPRIL HCL 150 139 29 44
POLYETHYLENE GLYCOL 3350 142 137 30 67
ENALAPRIL MALEATE 140 105 31 56
PANTOPRAZOLE SODIUM 137 130 32 34
DIOVAN 130 110 33 33
TRIAMTERENE-HCTZ 128 111 34 61
ZOLPIDEM TARTRATE 122 104 35 19
MUPIROCIN 120 114 36 121
GABAPENTIN 120 79 36 12
TAMSULOSIN HCL 120 120 36 32
AMLODIPINE BESYLATE-BENAZEPRIL 112 105 39 41
MEGESTROL ACETATE 111 111 R 40 92
AZITHROMYCIN 107 86 41 37
LOVASTATIN 106 96 42 46
FLUTICASONE PROPIONATE 105 85 43 39
RAMIPRIL 105 83 43 80
ALENDRONATE SODIUM 104 100 45 38
FENOFIBRATE 102 58 46 74
TRAZODONE HCL 99 70 47 40
DICLOFENAC SODIUM 99 97 47 96
CYMBALTA 98 51 49 45
ISOSORBIDE MONONITRATE ER 95 83 50 60
NOVOLIN R 95 71 50 153
FINASTERIDE 95 84 50 108
ESCITALOPRAM OXALATE 90 65 53 51
SYNTHROID 89 76 54 53
GLIPIZIDE 88 76 55 62
FLUOXETINE HCL 88 48 55 63
PERPHENAZINE-AMITRIPTYLINE 87 87 R 57 329
LANTUS 81 63 58 50
CRESTOR 80 72 59 25
TRICOR 79 52 60 98
ALBUTEROL SULFATE 79 68 60 162
CLOPIDOGREL 78 59 62 28
IPRATROPIUM-ALBUTEROL 78 78 62 193
NAPROXEN 78 30 62 84
QUETIAPINE FUMARATE 77 50 65 73
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 60 66 21
DIGOXIN 76 76 66 65
ACTOS 75 57 68 88
RISPERIDONE 74 53 69 78
CARVEDILOL 72 62 70 22
AMITRIPTYLINE HCL 71 71 R 71 43
ADVAIR DISKUS 70 53 72 52
LIPITOR 69 61 73 77
HYDROCHLOROTHIAZIDE 66 66 74 9
BUSPIRONE HCL 66 60 74 133
SPIRIVA 64 59 76 66
VERAPAMIL ER 64 64 76 87
TERAZOSIN HCL 62 45 78 142
EXELON 60 60 79 113
TRIAMCINOLONE ACETONIDE 59 47 80 160
ACTONEL 59 59 80 263
QUINAPRIL HCL 59 49 80 116
CYCLOBENZAPRINE HCL 59 31 R 80 64
OXYBUTYNIN CHLORIDE ER 59 37 80 154
PLAVIX 59 48 80 42
METOCLOPRAMIDE HCL 59 46 80 125
DIVALPROEX SODIUM ER 58 22 87 192
PAROXETINE HCL 55 55 88 68
CLONIDINE 55 44 88 242
CARBIDOPA-LEVODOPA 55 55 88 136
CIPROFLOXACIN HCL 54 48 91 58
DILTIAZEM HCL 53 45 92 235
PREDNISONE 53 28 92 47
AGGRENOX 52 40 94 219
DILTIAZEM 24HR ER 52 46 94 149
IBUPROFEN 52 33 94 101
LABETALOL HCL 52 43 94 208
GLIPIZIDE XL 51 51 98 128
DOXEPIN HCL 51 26 98 176
PREMARIN 51 41 R 98 105
LEVETIRACETAM 51 11 98 137
INDAPAMIDE 51 38 98 148
BACLOFEN 50 18 103 161
PROPRANOLOL HCL 50 44 103 141
CELEBREX 50 33 103 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.